GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (XCNQ:MYCO) » Definitions » Price-to-Funds-From-Operations

Mydecine Innovations Group (XCNQ:MYCO) Price-to-Funds-From-Operations : (As of Jun. 02, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Mydecine Innovations Group Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Mydecine Innovations Group (XCNQ:MYCO) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Executives
David Joshua Bartch Director